This report presents the results of a study that dealt specifically with effective communication around the benefit and risk balance of vaccination people’s risk perceptions around vaccines and diseases, and approaches to enhancing communication about the safety and effectiveness of vaccines.
ECDC, DG SANTE and EFSA, supported by a consortium composed of Epiconcept and Integrated Quality Laboratory Services (IQLS), jointly carried out a country visit to Kosovo* from 9 to 13 October 2023, which is part of ECDC’s accession support activities to contribute to the advancement of a One Health approach against antimicrobial resistance (AMR) in the Western Balkans.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
The Annual Epidemiological Reports (AERs) are a key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe.
This report contains genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 August 2023 until 31 January 2024.
ECDC cooperates with international partners, such as the World Health Organization and the centres for disease control and prevention (CDCs) across the globe.
ECDC also cooperates with EU candidate countries, potential candidate countries, and European Neighbourhood Policy (ENP) countries.
In the context of the antimicrobial resistance (AMR) conference of the Belgian EU presidency, with ECDC as one of the organisers, the Director participated in the high-level meeting ‘An EU Health Emergency’ in Brussels.